{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Tyra Biosciences, Inc."},"Symbol":{"label":"Symbol","value":"TYRA"},"Address":{"label":"Address","value":"2656 STATE STREET, CARLSBAD, California, 92008, United States"},"Phone":{"label":"Phone","value":"+1 619 728-4760"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Tyra Biosciences Inc is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer."},"CompanyUrl":{"label":"Company Url","value":"https://www.tyra.bio"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Daniel Bensen","title":"Chief Operating Officer"},{"name":"Jennifer Davis","title":"Head-Clinical"},{"name":"Melissa Neal","title":"Head-Research"},{"name":"Michael A. Bober","title":"VP-Clinical Development & Medical Affairs"},{"name":"Robert L. Hudkins","title":"Chief Technology Officer"},{"name":"Ronald V. Swanson","title":"Chief Scientific Officer"},{"name":"Todd J. Harris","title":"President, CEO, Treasurer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}